# Novo Nordisk Executive Faces Scrutiny for Weight-Loss Drug Prices – Senator Elizabeth Warren questions Novo Nordisk CEO about the high prices of weight-loss drugs. – Novo Nordisk CEO defends the prices by citing the high costs of research and development. – The company emphasizes the importance of affordable access to weight-loss medications for patients. – Novo Nordisk commits to working with policymakers to address concerns and find solutions. ### Novo Nordisk Remains Committed to Providing Affordable Weight-Loss Solutions Novo Nordisk’s CEO recently faced scrutiny in the US over the prices of weight-loss drugs during a congressional hearing led by Senator Elizabeth Warren. While the CEO defended the pricing strategy, highlighting the significant investments in research and development, the company also stressed the importance of ensuring affordable access to these essential medications for patients. Moving forward, Novo Nordisk commits to collaborating with policymakers to address concerns and explore innovative solutions to make weight-loss treatments more accessible to those in need. *Contact Mindful Evolution on our website [here](https://yourmindfulevolution.com) or call or text us at 954-639-9960 for personalized weight-loss solutions. Disclaimer: Weight loss results may vary. We offer telehealth services in Alabama, Arkansas, Florida, Georgia, Louisiana, Mississippi, North Carolina, New York, South Carolina, Tennessee, Texas, and Virginia.*